Advanced search
Publication Cover
Future Microbiology Volume 4, 2009 - Issue 9
Submit an article Journal homepage
645
Views
0
CrossRef citations to date
0
Altmetric
Review

The Vitamin D–Antimicrobial Peptide Pathway and its Role in Protection Against Infection

Adrian F GombartLinus Pauling Institute, Department of Biochemisty & Biophysics, Oregon State University, 2011 ALS Bldg, Corvallis, OR97331-7305, USA. Tel.: +1 541 737 8018 Fax: +1 541 737 [email protected]View further author information
Pages 1151-1165 | Published online: 06 Nov 2009

Bibliography

  • Bikle D : Nonclassic actions of vitamin D.J. Clin. Endocrinol. Metab.94(1) , 26–34 (2009).
  • Holick MF , ChenTC: Vitamin D deficiency: a worldwide problem with health consequences.Am. J. Clin. Nutr.87(4) , 1080S–1086S (2008).
  • Mangelsdorf DJ , ThummelC, BeatoM et al.: The nuclear receptor superfamily: the second decade.Cell83(6) , 835–839 (1995).
  • Christakos S , Raval-PandyaM, WernyjRP, YangW: Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.Biochem. J.316(Pt 2) , 361–371 (1996).
  • Bouillon R , GarmynM, VerstuyfA, SegaertS, CasteelsK, MathieuC: Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs.Eur. J. Endocrinol.133(1) , 7–16 (1995).
  • James SY , WilliamsMA, NewlandAC, ColstonKW: Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D.Gen. Pharmacol.32(1) , 143–154 (1999).
  • Zierold C , DarwishHM, DelucaHF: Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter.J. Biol. Chem.270(4) , 1675–1678 (1995).
  • Ren S , NguyenL, WuS, EncinasC, AdamsJS, HewisonM: Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis.J. Biol. Chem.280(21) , 20604–20611 (2005).
  • Provvedini D , TsoukasC, DeftosL, ManolagasS: 1,25-dihydroxyvitamin D3 receptors in human leukocytes.Science221(4616) , 1181–1183 (1983).
  • Bhalla AK , AmentoEP, ClemensTL, HolickMF, KraneSM: Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation.J. Clin. Endocrinol. Metab.57(6) , 1308–1310 (1983).
  • Deluca HF , CantornaMT: Vitamin D: its role and uses in immunology.FASEB J.15(14) , 2579–2585 (2001).
  • Adorini L , GiarratanaN, PennaG: Pharmacological induction of tolerogenic dendritic cells and regulatory T cells.Semin. Immunol.16(2) , 127–134 (2004).
  • Lemire JM , ArcherDC, BeckL, SpiegelbergHL: Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions.J. Nutr.125(Suppl. 6) , 1704S–1708S (1995).
  • Boonstra A , BarratFJ, CrainC, HeathVL, SavelkoulHF, O‘GarraA: 1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells.J. Immunol.167(9) , 4974–4980 (2001).
  • Penna G , AdoriniL: 1α,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation.J. Immunol.164(5) , 2405–2411 (2000).
  • Staeva-Vieira TP , FreedmanLP: 1,25-dihydroxyvitamin D3 inhibits IFN-γ and IL-4 levels during in vitro polarization of primary murine CD4+ T cells.J. Immunol.168(3) , 1181–1189 (2002).
  • Daniel C , SartoryNA, ZahnN, RadekeHH, SteinJM: Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.J. Pharmacol. Exp. Ther.324(1) , 23–33 (2008).
  • Adorini L , PennaG: Dendritic cell tolerogenicity in immunomodulation by vitamin D receptor agonists.Hum. Immunol. (2009) (Epub ahead of print).
  • Adorini L , PennaG: Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists.Hum. Immunol.70(5) , 345–352 (2009).
  • Adorini L , PennaG, GiarratanaN et al.: Dendritic cells as key targets for immunomodulation by vitamin D receptor ligands.J. Steroid Biochem. Mol. Biol.89–90(1–5) , 437–441 (2004).
  • Adorini L : Intervention in autoimmunity: the potential of vitamin D receptor agonists.Cell Immunol.233(2) , 115–124 (2005).
  • Mathieu C , AdoriniL: The coming of age of 1,25-dihydroxyvitamin D(3) analogs as immunomodulatory agents.Trends Mol. Med.8(4) , 174–179 (2002).
  • Adorini L , PennaG: Control of autoimmune diseases by the vitamin D endocrine system.Nat. Clin. Pract. Rheumatol.4(8) , 404–412 (2008).
  • Chen S , SimsGP, ChenXX, GuYY, LipskyPE: Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation.J. Immunol.179(3) , 1634–1647 (2007).
  • Liu PT , StengerS, LiH et al.: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response.Science311(5768) , 1770–1773 (2006).
  • Overbergh L , DecallonneB, WaerM et al.: 1α,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524–543).Diabetes49(8) , 1301–1307 (2000).
  • Koeffler HP , ReichelH, BishopJE, NormanAW: γ-interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages.Biochem. Biophys. Res. Commun.127(2) , 596–603 (1985).
  • Hewison M , KantorovichV, LikerHR et al.: Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages.J. Bone Miner. Res.18(3) , 579–582 (2003).
  • Cadranel J , HanceAJ, MilleronB, PaillardF, AkounGM, GarabedianM: Vitamin D metabolism in tuberculosis. Production of 1,25(OH)2D3 by cells recovered by bronchoalveolar lavage and the role of this metabolite in calcium homeostasis.Am. Rev. Respir. Dis.138(4) , 984–989 (1988).
  • Reichel H , KoefflerHP, NormanAW: Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-γ-stimulated normal human bone marrow and alveolar macrophages.J. Biol. Chem.262(23) , 10931–10937 (1987).
  • Yu XP , BellidoT, ManolagasSC: Down-regulation of NF-κb protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3.Proc. Natl Acad. Sci. USA92(24) , 10990–10994 (1995).
  • Harant H , AndrewPJ, ReddyGS, FoglarE, LindleyIJ: 1α,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-κb-mediated interleukin-8 gene expression.Eur. J. Biochem.250(1) , 63–71 (1997).
  • Sun J , KongJ, DuanY et al.: Increased NF-κb activity in fibroblasts lacking the vitamin D receptor.Am. J. Physiol. Endocrinol. Metab.291(2) , E315–E322 (2006).
  • Van Etten E , MathieuC: Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts.J. Steroid Biochem. Mol. Biol.97(1–2) , 93–101 (2005).
  • Rajapakse R , MousliM, PfaffAW et al.: 1,25-dihydroxyvitamin D3 induces splenocyte apoptosis and enhances BALB/C mice sensitivity to toxoplasmosis.J. Steroid Biochem. Mol. Biol.96(2) , 179–185 (2005).
  • Ehrchen J , HelmingL, VargaG et al.: Vitamin D receptor signaling contributes to susceptibility to infection with Leishmania major.FASEB J.21(12) , 3208–3218 (2007).
  • Martineau AR , WilkinsonKA, NewtonSM et al.: IFN-γ- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37.J. Immunol.178(11) , 7190–7198 (2007).
  • Gombart AF , BorregaardN, KoefflerHP: Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3.FASEB J.19(9) , 1067–1077 (2005).
  • Wang TT , NestelFP, BourdeauV et al.: Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression.J. Immunol.173(5) , 2909–2912 (2004).
  • Weber G , HeilbornJD, Chamorro Jimenez CI, Hammarsjo A, Torma H, Stahle M: Vitamin D induces the antimicrobial protein hCAP18 in human skin. J. Invest. Dermatol.124(5) , 1080–1082 (2005).
  • Zasloff M : Fighting infections with vitamin D.Nat. Med.12(4) , 388–390 (2006).
  • Gombart AF , O‘KellyJ, SaitoT, KoefflerHP: Regulation of the CAMP gene by 1,25(OH)2D3 in various tissues.J. Steroid Biochem. Mol. Biol.103(3–5) , 552–557 (2007).
  • Schauber J , DorschnerRA, CodaAB et al.: Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism.J. Clin. Invest.117(3) , 803–811 (2007).
  • Liu PT , SchenkM, WalkerVP et al.: Convergence of IL-1β and VDR activation pathways in human TLR2/1-induced antimicrobial responses.PLoS One4(6) , e5810 (2009).
  • Zanetti M , GennaroR, RomeoD: Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain.FEBS Lett.374(1) , 1–5 (1995).
  • Sorensen OE , FollinP, JohnsenAH et al.: Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3.Blood97(12) , 3951–3959 (2001).
  • Lehrer RI , GanzT: Cathelicidins: a family of endogenous antimicrobial peptides.Curr. Opin. Hematol.9(1) , 18–22 (2002).
  • Zanetti M , GennaroR, ScocchiM, SkerlavajB: Structure and biology of cathelicidins.Adv. Exp. Med. Biol.479 , 203–218 (2000).
  • Frohm Nilsson M , SandstedtB, SorensenO, WeberG, BorregaardN, Stahle-BackdahlM: The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6.Infect. Immun.67(5) , 2561–2566 (1999).
  • Bals R , WangX, ZasloffM, WilsonJM: The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface.Proc. Natl Acad. Sci. USA95(16) , 9541–9546 (1998).
  • Murakami M , OhtakeT, DorschnerRA, GalloRL: Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva.J. Dent. Res.81(12) , 845–850 (2002).
  • Murakami M , OhtakeT, DorschnerRA, SchittekB, GarbeC, GalloRL: Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin.J. Invest. Dermatol.119(5) , 1090–1095 (2002).
  • Agerberth B , GunneH, OdebergJ, KognerP, BomanHG, GudmundssonGH: Fall-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis.Proc. Natl Acad. Sci. USA92(1) , 195–199 (1995).
  • Malm J , SorensenO, PerssonT et al.: The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to spermatozoa.Infect. Immun.68(7) , 4297–4302 (2000).
  • Hammami-Hamza S , DoussauM, BernardJ et al.: Cloning and sequencing of SOB3, a human gene coding for a sperm protein homologous to an antimicrobial protein and potentially involved in zona pellucida binding.Mol. Hum. Reprod.7(7) , 625–632 (2001).
  • Andersson E , SorensenOE, FrohmB, BorregaardN, EgestenA, MalmJ: Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes.Hum. Reprod.17(10) , 2529–2534 (2002).
  • Agerberth B , CharoJ, WerrJ et al.: The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations.Blood96(9) , 3086–3093 (2000).
  • Di Nardo A , VitielloA, GalloRL: Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide.J. Immunol.170(5) , 2274–2278 (2003).
  • Sorensen O , ArnljotsK, CowlandJB, BaintonDF, BorregaardN: The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils.Blood90(7) , 2796–2803 (1997).
  • Dorschner RA , PestonjamaspVK, TamakuwalaS et al.: Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus.J. Invest. Dermatol.117(1) , 91–97 (2001).
  • Ong PY , OhtakeT, BrandtC et al.: Endogenous antimicrobial peptides and skin infections in atopic dermatitis.N. Engl. J. Med.347(15) , 1151–1160 (2002).
  • Frohm M , AgerberthB, AhangariG et al.: The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders.J. Biol. Chem.272(24) , 15258–15263 (1997).
  • Nizet V , OhtakeT, LauthX et al.: Innate antimicrobial peptide protects the skin from invasive bacterial infection.Nature414(6862) , 454–457 (2001).
  • Chromek M , SlamovaZ, BergmanP et al.: The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection.Nat. Med.12(6) , 636–641 (2006).
  • Putsep K , CarlssonG, BomanHG, AnderssonM: Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.Lancet360(9340) , 1144–1149 (2002).
  • Gombart AF , KoefflerHP: Neutrophil specific granule deficiency and mutations in the gene encoding transcription factor c/ebp(e).Curr. Opin. Hematol.9(1) , 36–42 (2002).
  • Yang YH , ZhengGG, LiG, ZhangB, SongYH, WuKF: Expression of LL-37/hCAP-18 gene in human leukemia cells.Leuk. Res.27(10) , 947–950 (2003).
  • Ganz T : Defensins: antimicrobial peptides of vertebrates.C. R. Biol.327(6) , 539–549 (2004).
  • Davies PD : A possible link between vitamin D deficiency and impaired host defence to Mycobacterium tuberculosis.Tubercle66(4) , 301–306 (1985).
  • Wilkinson RJ , LlewelynM, ToossiZ et al.: Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in West London: a case–control study.Lancet355(9204) , 618–621 (2000).
  • Nnoaham KE , ClarkeA: Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis.Int. J. Epidemiol.37(1) , 113–119 (2008).
  • Rook GA , SteeleJ, FraherL et al.: Vitamin D3, γ-interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes.Immunology57(1) , 159–163 (1986).
  • Liu PT , StengerS, TangDH, ModlinRL: Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin.J. Immunol.179(4) , 2060–2063 (2007).
  • Martineau AR , HoneckerFU, WilkinsonRJ, GriffithsCJ: Vitamin D in the treatment of pulmonary tuberculosis.J. Steroid Biochem. Mol. Biol.103(3–5) , 793–798 (2007).
  • Nursyam EW , AminZ, RumendeCM: The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion.Acta Med. Indones.38(1) , 3–5 (2006).
  • Morcos MM , GabrAA, SamuelS et al.: Vitamin D administration to tuberculous children and its value.Boll. Chim. Farm.137(5) , 157–164 (1998).
  • Martineau AR , WilkinsonRJ, WilkinsonKA et al.: A single dose of vitamin D enhances immunity to mycobacteria.Am. J. Respir. Crit. Care Med.176(2) , 208–213 (2007).
  • Wejse C , GomesVF, RabnaP et al.: Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.Am. J. Respir. Crit. Care Med.179(9) , 843–850 (2009).
  • Martineau AR , NanzerAM, SatkunamKR et al.: Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients.Int. J. Tuberc. Lung Dis.13(1) , 119–125 (2009).
  • Laaksi I , RuoholaJP, TuohimaaP et al.: An association of serum vitamin D concentrations < 40 nmol/l with acute respiratory tract infection in young Finnish men.Am. J. Clin. Nutr.86(3) , 714–717 (2007).
  • Karatekin G , KayaA, SalihogluO, BalciH, NuhogluA: Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers.Eur. J. Clin. Nutr.63(4) , 473–477 (2009).
  • Walker VP , ModlinRL: The vitamin D connection to pediatric infections and immune function.Pediatr. Res. (2009) (Epub ahead of print).
  • Ginde AA , MansbachJM, CamargoCA Jr: Vitamin D, respiratory infections, and asthma. Curr. Allergy Asthma Rep.9(1) , 81–87 (2009).
  • Cannell JJ , ViethR, UmhauJC et al.: Epidemic influenza and vitamin D.Epidemiol. Infect.134(6) , 1129–1140 (2006).
  • Bodnar LM , KrohnMA, SimhanHN: Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy.J. Nutr.139(6) , 1157–1161 (2009).
  • Villamor E : A potential role for vitamin D on HIV infection?Nutr. Rev.64(5 Pt 1) , 226–233 (2006).
  • Hansdottir S , MonickMM, HindeSL, LovanN, LookDC, HunninghakeGW: Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense.J. Immunol.181(10) , 7090–7099 (2008).
  • Gombart AF , SaitoT, KoefflerHP: Exapation of an ancient ALU short interspersed element provides a highly conserved vitamin D-mediated innate immune response in humans and primates.BMC Genomics10(1) , 321 (2009).
  • Hase K , EckmannL, LeopardJD, VarkiN, KagnoffMF: Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium.Infect. Immun.70(2) , 953–963 (2002).
  • Erdag G , MorganJR: Interleukin-1α and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts.Ann. Surg.235(1) , 113–124 (2002).
  • Sorensen OE , CowlandJB, Theilgaard-MonchK, LiuL, GanzT, BorregaardN: Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors.J. Immunol.170(11) , 5583–5589 (2003).
  • Schauber J , SvanholmC, TermenS et al.: Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways.Gut52(5) , 735–741 (2003).
  • Schauber J , DorschnerRA, YamasakiK, BrouhaB, GalloRL: Control of the innate epithelial antimicrobial response is cell-type specific and dependent on relevant microenvironmental stimuli.Immunology118(4) , 509–519 (2006).
  • Islam D , BandholtzL, NilssonJ et al.: Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator.Nat. Med.7(2) , 180–185 (2001).
  • Chakraborty K , GhoshS, KoleyH et al.: Bacterial exotoxins downregulate cathelicidin (hCAP-18/LL-37) and human β-defensin 1 (HBD-1) expression in the intestinal epithelial cells.Cell Microbiol.10(12) , 2520–2537 (2008).
  • Vieth R : What is the optimal vitamin D status for health?Prog. Biophys. Mol. Biol.92(1) , 26–32 (2006).
  • Adams JS , RenS, LiuPT et al.: Vitamin D-directed rheostatic regulation of monocyte antibacterial responses.J. Immunol.182(7) , 4289–4295 (2009).
  • Krutzik SR , HewisonM, LiuPT et al.: IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway.J. Immunol.181(10) , 7115–7120 (2008).
  • Lande R , GregorioJ, FacchinettiV et al.: Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide.Nature449(7162) , 564–569 (2007).
  • Ganguly D , ChamilosG, LandeR et al.: Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8.J. Exp. Med.206(9) , 1983–1994 (2009).
  • Peric M , KoglinS, KimSM et al.: IL-17α enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes.J. Immunol.181(12) , 8504–8512 (2008).
  • Wolk K , KunzS, WitteE, FriedrichM, AsadullahK, SabatR: IL-22 increases the innate immunity of tissues.Immunity21(2) , 241–254 (2004).
  • Kao CY , ChenY, ThaiP et al.: IL-17 markedly up-regulates β-defensin-2 expression in human airway epithelium via JAK and NF-κb signaling pathways.J. Immunol.173(5) , 3482–3491 (2004).
  • Peric M , KoglinS, DombrowskiY et al.: Vitamin D analogs differentially control antimicrobial peptide/“Alarmin” expression in psoriasis.PLoS One4(7) , e6340 (2009).
  • Buchau AS , MacleodDT, MorizaneS, KotolPF, HataT, GalloRL: Bcl-3 acts as an innate immune modulator by controlling antimicrobial responses in keratinocytes.J. Invest. Dermatol.129(9) , 2148–2155 (2009).
  • Chawla A , RepaJJ, EvansRM, MangelsdorfDJ: Nuclear receptors and lipid physiology: opening the X-files.Science294(5548) , 1866–1870 (2001).
  • Schmidt DR , MangelsdorfDJ: Nuclear receptors of the enteric tract: guarding the frontier.Nutr. Rev.66(10 Suppl. 2) , S88–S97 (2008).
  • Makishima M , OkamotoAY, RepaJJ et al.: Identification of a nuclear receptor for bile acids.Science284(5418) , 1362–1365 (1999).
  • Adachi R , HonmaY, MasunoH et al.: Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative.J. Lipid Res.46(1) , 46–57 (2005).
  • Staudinger JL , GoodwinB, JonesSA et al.: The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity.Proc. Natl Acad. Sci. USA98(6) , 3369–3374 (2001).
  • Xie W , Radominska-PandyaA, ShiY et al.: An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids.Proc. Natl Acad. Sci. USA98(6) , 3375–3380 (2001).
  • Matsubara T , YoshinariK, AoyamaK et al.: Role of vitamin D receptor in the lithocholic acid-mediated CYP3a induction in vitro and in vivo.Drug Metab. Dispos.36(10) , 2058–2063 (2008).
  • Ogura M , NishidaS, IshizawaM et al.: Vitamin D3 modulates the expression of bile acid regulatory genes and represses inflammation in bile duct-ligated mice.J. Pharmacol. Exp. Ther.328(2) , 564–570 (2009).
  • Lorenzo-Zuniga V , BartoliR, PlanasR et al.: Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats.Hepatology37(3) , 551–557 (2003).
  • Inagaki T , MoschettaA, LeeYK et al.: Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor.Proc. Natl Acad. Sci. USA103(10) , 3920–3925 (2006).
  • D‘aldebert E , Biyeyeme Bi Mve MJ, Mergey M et al.: Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium. Gastroenterology136(4) , 1435–1443 (2009).
  • Schwab M , ReyndersV, ShastriY, LoitschS, SteinJ, SchroderO: Role of nuclear hormone receptors in butyrate-mediated up-regulation of the antimicrobial peptide cathelicidin in epithelial colorectal cells.Mol. Immunol.44(8) , 2107–2114 (2007).
  • Jurutka PW , BartikL, WhitfieldGK et al.: Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.J. Bone Miner. Res.22(Suppl. 2) , V2–V10 (2007).
  • Jacobsen F , MittlerD, HirschT et al.: Transient cutaneous adenoviral gene therapy with human host defense peptide hCAP-18/LL-37 is effective for the treatment of burn wound infections.Gene Ther.12(20) , 1494–1502 (2005).
  • Raqib R , SarkerP, BergmanP et al.: Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic.Proc. Natl Acad. Sci. USA103(24) , 9178–9183 (2006).
  • Zasloff M : Inducing endogenous antimicrobial peptides to battle infections.Proc. Natl Acad. Sci. USA103(24) , 8913–8914 (2006).
  • Gombart AF , BhanI, BorregaardN et al.: Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis.Clin. Infect. Dis.48(4) , 418–424 (2009).
  • Jeng L , YamshchikovAV, JuddSE et al.: Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis.J. Transl. Med.7 , 28 (2009).
  • Hata TR , KotolP, JacksonM et al.: Administration of oral vitamin D induces cathelicidin production in atopic individuals.J. Allergy Clin. Immunol.122(4) , 829–831 (2008).
  • Oppenheim JJ , TewaryP, De La Rosa G, Yang D: Alarmins initiate host defense. Adv. Exp. Med. Biol.601 , 185–194 (2007).
  • Yang D , De La Rosa G, Tewary P, Oppenheim JJ: Alarmins link neutrophils and dendritic cells. Trends Immunol. (2009) (Epub ahead of print).
  • Nehring JA , ZieroldC, DelucaHF: Lithocholic acid can carry out in vivo functions of vitamin D.Proc. Natl Acad. Sci. USA104(24) , 10006–10009 (2007).
  • Ishizawa M , MatsunawaM, AdachiR et al.: Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia.J. Lipid Res.49(4) , 763–772 (2008).
  • Holick MF : The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.Mol. Aspects Med.29(6) , 361–368 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.